Forian Inc.
2.08
0.02 (0.97%)
At close: Jan 14, 2025, 3:59 PM
2.08
0.00%
After-hours Jan 14, 2025, 04:00 PM EST

Company Description

Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers.

It operates through three segments: Information & Software, Services, and Other.

The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance.

Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies.

In addition, the company offers security monitoring and web marketing services.

The company is headquartered in Newtown, Pennsylvania.

Forian Inc.
Forian Inc. logo
Country United States
IPO Date Mar 3, 2021
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 36
CEO Max C. Wygod

Contact Details

Address:
41 University Drive
Newtown, Pennsylvania
United States
Website https://forian.com

Stock Details

Ticker Symbol FORA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001829280
CUSIP Number 34630N106
ISIN Number US34630N1063
Employer ID 85-3467693
SIC Code 7374

Key Executives

Name Position
Max C. Wygod Co-Founder, Chief Executive Officer, President & Executive Chairman of the Board
Adam H. Dublin Co-Founder, Chief Strategy Officer & Director
Edward Francis Spaniel Jr. Executive Vice President, General Counsel & Secretary
Jason Holden Vice President of Corporate Development
Paul Reuscher Chief Commercial Officer

Latest SEC Filings

Date Type Title
Jan 14, 2025 4 Filing
Jan 14, 2025 4 Filing
Nov 13, 2024 10-Q Quarterly Report
Nov 13, 2024 8-K Current Report
Nov 12, 2024 4 Filing
Nov 12, 2024 4 Filing
Nov 06, 2024 8-K Current Report
Sep 13, 2024 4 Filing
Aug 14, 2024 10-Q Quarterly Report
Aug 14, 2024 8-K Current Report